Biosearch Life
Granada, 18004, Spain
NCT Number: NCT01346644
In the last years manipulation of intestinal microbiota with probiotics has gained an increasing interest, specially in infant nutrition since recent studies has demonstrated the presence of probiotics in human milk. However, there are few studies studying the effects of probiotics in newborns. The objective of the present study is to analyze safety and tolerance of the probiotic Lactobacillus fermentum CECT5716 isolated from human milk.
Looking for future studies?
Notify Me21 day–30 day
All sexes
Interventional
Not applicable
Granada, 18004, Spain
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Powder infant formula
Time frame: 4 months
Time frame: 2,4,6,12 and 36 months of life
average weight, length of infants. Incidence of infections. Incidence of allergic diseases
Puleva Biotech
Industry
Study of Tolerance of an Infant Formula Supplemented With Lactobacillus Fermentum CECT5716
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07302477
Adverse Event, Growth
Chak Four Hundred Fifty-four, Pakistan
View Trial DetailsNCT04576507
Cannabis, Chemically-Induced Disorders
New York, United States
View Trial DetailsNCT05978908
Safety Issues, Tolerance
Berlin, New Jersey, United States
View Trial DetailsNCT06232460
Tolerance
Chicago, Illinois, United States
View Trial Details